When the Food and Drug Administration suddenly pulled the Johnson & Johnson coronavirus vaccine from distribution over concerns about very rare blood clotting, many people were worried the FDA’s decision would have a far-reaching effect on the public’s trust in the vaccine. It turns out they were right.

A new poll found that only one in four people not yet immunized against the coronavirus say they would be willing to get the Johnson & Johnson vaccine, and fewer than half of U.S. adults now say they consider the Johnson & Johnson vaccine very or somewhat safe. In comparison, more than seven in 10 people said they regard the Moderna and Pfizer vaccines to be very or somewhat safe.